BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2013
View Archived Issues
International trial of rhNGF begins in the treatment of neurotrophic keratitis
Read More
Roche presents potential predictivity of preclinical cancer models
Read More
177Lu-J-591 shows promising antitumor activity at the MTD of 70 mCi/m2
Read More
Shin Nippon Biomedical Laboratories and Kyoto University enter agreement
Read More
Mylan enters generic insulin agreement with Biocon
Read More
Antitumor activity demonstrated for TRAIL-inducing compound TIC-10
Read More
Dako launches nontoxic FISH assay for cancer diagnosis in U.S.
Read More
Third Rock Ventures launches new company with a focus on cancer immunotherapy
Read More
Emory University and Health Research patent new TAK1 inhibitors
Read More
Novartis presents final results of a phase II study of dovitinib in urothelial cancer
Read More
FDA grants orphan drug status to OSE-2101
Read More
GlaxoSmithKline presents novel Lp-PLA2 inhibitors
Read More
Nerviano Medical Sciences divulges new protein kinase inhibitors
Read More
Novel c-Kit inhibitors presented by AB Science
Read More
Researchers at Allergan synthesize new alpha-adrenoceptor agonists
Read More
Phase II results for linsitinib in mCRPC presented
Read More
Livalo OD tablets approved in Japan for hypercholesteremia
Read More
FDA advisory committee recommends approval of contrast agent Dotarem
Read More
FDA accepts Oralair BLA for review
Read More
Piromelatine shows promise in phase II insomnia trial
Read More
Verastem compounds target cancer stem cells
Read More
FDA approves Zortress in new indication
Read More
Scientists at Grunenthal prepare novel TRPV1 ligands
Read More
Lilly and QIAGEN to collaborate on companion diagnostics
Read More
FDA grants priority review to dolutegravir NDA
Read More
Phase II trial of Cogane in Parkinson's disease misses endpoints
Read More
FDA approves Argus II Retinal Prosthesis System for patients with advanced retinitis pigmentosa
Read More